G allstone disease (GSD), a condition with crystalline deposits in the gallbladder, is one of the most common and costly gastrointestinal disorders resulting in hospital admission in developed countries. 1 To a relatively lower degree, GSD is also a common health problem in Asian populations, such as Chinese; 2 and the prevalence has been increasing along with growing adoption of western lifestyle and epidemic of obesity. 3
Results
At baseline, 5.8% of 487 373 participants reported the presence of GSD (men 3.7%; women 7.3%). Age-and site-adjusted baseline characteristics according to the presence of GSD are presented in Table 1 . Compared with participants without GSD, those with GSD were older, more likely to be urban residents, less likely to smoke tobacco and drink alcohol, less physically active, and had higher body mass index, waist circumference, and prevalence of diabetes mellitus, chronic hepatitis/cirrhosis, and peptic ulcer ( Table 1 ). Women with GSD had an earlier age at the first diagnosis and longer duration than men with GSD.
During a median follow-up of 7.2 years (interquartile range, 1.91 years; total person-years, 3 431 124), we documented 10 245 incident IHD cases in men (1034 [10. 1%] fatal and 9211 [89.9%] nonfatal) and 14 714 in women (767 [5. 2%] fatal and 13 947 [94.8%] nonfatal). Incidence rates according to the presence of GSD were 7.1 and 9.8 deaths per 1000 person-years for participants without and with GSD, respectively. Figure 1 presents the Nelson-Aalen curves of the cumulative hazard of IHD according to the presence of GSD. The cumulative incidence of IHD was statistically significantly higher in participants with GSD than in those without GSD (log-rank test, P<0.001). In age-adjusted analyses, the presence of GSD was significantly associated with an increased risk of incident IHD. Further adjustment for other potential confounders, especially body mass index, hypertension, diabetes mellitus, and several lifestyle risk factors, did not substantially attenuate these associations ( Table 2) . As compared with men without GSD at baseline, the multivariate-adjusted hazard ratio (HR) for IHD was 1.11 (95% confidence interval [CI], 1.02−1.22) for men with GSD; the respective HR was 1.27 (95% CI, 1.20−1.34) in women and 1.23 (95% CI, 1.17−1.28) in the whole cohort. We found that the association between GSD and IHD was significantly stronger in women than in men (P=0.009 for interaction with sex). These associations were not materially changed in sensitivity analyses with additional adjustment for the presence of digestive system diseases, replacement of body mass index by waist circumference, or exclusion of patients with diabetes mellitus ( Table 2) .
We further performed stratified analyses according to the duration of GSD from the first diagnosis to the baseline. Similar associations were observed among participants with different durations of GSD in the whole cohort. Notably, the association of GSD with incident IHD appeared to be stronger in women than in men among those who reported their duration of GSD since the first diagnosis >10 years ( Table 3) .
We also analyzed the associations between GSD and incident IHD according to other potential baseline risk factors; the positive associations were generally similar across subgroups stratified according to age, smoking status, alcohol consumption, level of physical activity, body mass index, abdominal obesity measured by waist circumference, and the presence of diabetes mellitus (all P values for interaction >0.05; Figure 2 ; Table I in the online-only Data Supplement). Statistically significant difference across strata was observed for the presence of hypertension in women (P<0.001 for interaction) but not in men (P=0.216 for interaction), with a stronger association in nonhypertensive than in hypertensive women.
Discussion
In this large prospective study with >3.4 million person-years of follow-up, we found that presence of GSD was associated with a significantly increased risk of incident IHD, and such association was independent of traditional cardiovascular risk factors. The association was stronger in women than in men and was stronger in nonhypertensive than in hypertensive women.
Our findings are consistent with the results from 4 previous smaller prospective studies. In those studies, a history of GSD was associated with an increased risk of coronary heart disease (odds ratio =1.75; 95% CI, 1.13−2.69) among men in the Framingham Heart Study, 9 CVD mortality (HR=1.4; 95% CI, 1.2−1.7) in a general US population from the third US National Health and Nutrition Examination Survey, 10 CVD, including myocardial infarction and stroke (HR=1.24; 95% CI, 1.02−1.50), in the German arm of the European Prospective Investigation into Cancer and Nutrition (EPIC), 11 and coronary heart disease (HR=1.42; 95% CI, 1.28−1.58) in a Taiwan population identified from the Taiwan National Health Insurance Research Database (NHIRD). 12 In addition, in a retrospective cohort study based on Taiwan NHIRD, persons with GSD were also found to have an increased risk of developing ischemic (HR=1.28; 95% CI, 1.25−1.31) and hemorrhagic stroke (HR=1.33; 95% CI, 1.25−1.41). 13 Several potential mechanisms may account for the association between GSD and cardiovascular risk. Presence of GSD has been related to a variety of cardiovascular risk factors, such as obesity, 16, 17 hyperinsulinemia, 18, 19 insulin resistance, 20 diabetes mellitus, 19, 21 and metabolic syndrome. 22 However, in our study, the association of GSD with IHD risk remained significant after adjustment for obesity, hypertension, diabetes mellitus, and common lifestyle risk factors, suggesting other mechanisms might also be involved.
In a recent study, it was found that GSD was related to gut microbiota dysbiosis, 4 probably through distorted secretion of bile acids that play a key role in regulating abundance or metabolism of gut microbiota. 23 Gut microbiota has recently emerged as a novel risk factor for CVD, and several studies have associated gut microbiota-related metabolites, such as trimethylamine-N-oxide and L-carnitine, with risk of CVD and mortality. 6, 24 In addition, abundance of gut microbiota has been related to elevated levels of CVD risk factors, including inflammation and dyslipidemia, through metabolic endotoxemia. 25, 26 We assume that the association between GSD and IHD might be at least partly through affecting gut microbiota metabolism; our findings would motivate further investigation on this hypothesis.
In our study, the risk for incident IHD associated with GSD differed by sex and was stronger in women than in men. Estrogen has been suggested to be an important risk factor for the formation of cholesterol gallstones, leading to observations that cholesterol gallstones are more common in women than in men, and such sex difference begins from puberty and continues through the childbearing years. 27 Sustained effect of estrogen on gallstone Nonstandard Abbreviations and Acronyms CVD cardiovascular disease GSD gallstone disease IHD ischemic heart disease formation may also account for a potentially more important etiologic role of GSD in the development of IHD in women than in men. This result was different from the findings from previous studies, which reported either no sex difference [10] [11] [12] or stronger association in men. 9 The discrepant observations may be partly explained by population diversity. In addition, the previous studies were largely small in size and might have be underpowered to detect such sex difference. How sex may affect the association between GSD and IHD warrants further investigations. In addition, we observed statistically significant interaction between GSD and hypertension on IHD risk, and stronger association was observed in nonhypertensive than in hypertensive women. GSD and hypertension may partially share common pathogenic mechanisms that contribute to the increased risk of IHD. It is possible that hypertensive patients were already at a high risk of IHD, and GSD status added only modestly deleterious effect on the relative scale. However, it is notable that the absolute risk associated with hypertension among women with GSD was much greater than that without hypertension. In addition, antihypertensive therapy or lifestyle modifications among hypertensive patients may play an antagonistic role on the pathways involved in the development of IHD among women with both conditions. Further study is needed to clarify the possible biological mechanisms underlying differential effects of GSD on IHD by hypertension. No interaction was observed between GSD and hypertension on The results are presented as adjusted means or percentages. All variables are adjusted for age and survey sites, as appropriate. BMI indicates body mass index; GSD, gallstone disease; MET, metabolic equivalent task; and WC, waist circumference.
*The average weekly consumptions of red meat, fresh vegetables, and fruits were calculated by assigning participants the midpoint of their consumption category. †There were statistically significant differences in both the age at the first diagnosis and the duration since the first diagnosis between men and women (P<0.001). IHD risk in men, probably partly because of less important etiologic role of GSD in men than in women.
Our study had several strengths. To our knowledge, this was thus far the largest prospective study assessing time-dependent association between GSD and incident IHD. We carefully controlled for a wide range of established and potential confounders associated with CVD. We excluded participants with a history of CVD at baseline to minimize the influence of possible reverse causation. However, our results need to be interpreted in the context of a few limitations. First, one of the main limitations was that the study relied on self reporting of the presence of GSD, potentially leading to misclassification of exposures. However, previous smaller prospective studies using GSD diagnosed by gallbladder ultrasonography 10 or based on medical records showed similar findings. 12 In addition, in a prospective study design, measurement errors with regard to GSD may be nondifferential, and the association is more likely to be biased toward the null. Second, we did not collect specific information on the subtypes of gallstone. However, because most gallstones in the Chinese population have been of the cholesterol type since the early 1990s, 28 we expected that lack of such information might only have minor impact on the results. Our data were also not able to identify the severity of GSD, such as asymptomatic, symptomatic, or having performed cholecystectomy. This could limit our in-depth analysis to explore this association of interest to a further extent. Third, although we have carefully adjusted for a broad range of known or potential risk factors, residual confounding by other unmeasured or unknown factors, such as dyslipidemia and hyperinsulinemia, was still possible. For example, if dyslipidemia confounds the observed association between GSD and IHD but was not controlled for, it would have potentially led to an overestimation of observed association and biased our results away from the null value. The multivariate models were adjusted for the following baseline factors: age; sex (for whole cohort only); level of education; marital status; alcohol consumption; smoking status; level of physical activity; intake frequencies of red meat, fresh fruits, and vegetables; prevalent hypertension; prevalent diabetes mellitus; family history of heart attack; menopausal status (for women only); and body mass index. CI denotes confidence intervals; and GSD, gallstone disease.
Figure 2.
Subgroup analyses of association between gallstone disease and ischemic heart disease according to potential baseline risk factors. Adjustments were made for age; education; marital status; alcohol consumption; smoking status; physical activity; intakes of red meat, fresh fruits, and vegetables; hypertension; diabetes mellitus; family history of heart attack; menopausal status (for women only); and body mass index. CI indicates confidence interval; and MET, metabolic equivalent task. and its regional offices for access to death and disease registries. The Chinese National Health Insurance scheme provides electronic linkage to all hospital treatment.
